Document ID: chunk:federal_register_of_legislation:F2025C00039:reg:72814
Version: federal_register_of_legislation:F2025C00039
Segment Type: reg
Provision Reference: reg 72814
Character Range: 4816–6033

72814                      Immunohistochemical examination by immunoperoxidase or other labelled antibody techniques using the programmed cell death ligand 1 (PD‑L1) antibody of tumour material from a patient diagnosed with:  74.50
                             (a) non‑small cell lung cancer; or
                             (b) recurrent or metastatic squamous cell carcinoma of the oral cavity, pharynx or larynx; or
                             (c) locally recurrent unresectable or metastatic triple‑negative breast cancer.

Group P7—Genetics
Item               Description                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Fee ($)